Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
**Charity number: 700037**
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **UNAUDITED**
**TRUSTEES' REPORT AND FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 5 APRIL 2025**
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
|**CONTENTS**||
|---|---|
||Page|
|**Reference and administrative details of the Charity, its Trustees and advisers**|1|
|**Trustees' report**|2 - 5|
|**Independent examiner's report**|6|
|**Statement of financial activities**|7|
|**Balance sheet**|8|
|**Notes to the financial statements**|9 - 19|
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 5 APRIL 2025**
|**Trustees**|JA Kirby, Chair from 29 October 2024 (appointed 29 October 2024)|
|---|---|
||THJ Goodship, Chair to 29 October 2024 (resigned 29 October 2024)|
||NS Sheerin|
||S Johnson|
||AM Steel (appointed 28 January 2025)|
||NJ Channon|
|**Charity registered**
**number**
700037
**Principal office**
Level 4 Podium Block
Freeman Hospital
Newcastle upon Tyne
NE7 7DN
**Accountants**
Ryecroft Glenton
Chartered Accountants
32 Portland Terrace
Newcastle upon Tyne
NE2 1QP
**Bankers**
Barclays Bank plc
49-51 Northumberland Street
Newcastle upon Tyne
NE1 7AF
**Stockbroker**
Barclays Wealth Management
Tay House
300 Bath Street
Glasgow
G2 4LH||
Page 1
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
**TRUSTEES' REPORT FOR THE YEAR ENDED 5 APRIL 2025**
The Trustees present their annual report together with the financial statements of Northern Counties Kidney Research Fund ("the Charity") for the year 6 April 2024 to 5 April 2025.
## **Objectives and activities**
## **Policies and objectives**
The Charity provides funds for kidney research. The Trustees limit the geographical spread of the Charity's activities to the Counties of Cumbria, Durham, Tyne & Wear and Northumberland. Within these areas, the Charity will fund both projects and posts where there is a definable benefit to kidney research arising out of the funding.
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
## **Strategies for achieving objectives**
Projects and posts requiring funding must be research orientated. The Charity will part-fund larger projects and projects not wholly orientated towards kidney research where the element of research not related to kidneys is small. The Charity will also underwrite new projects and research posts for a period of time where there is the possibility that longer term funding may be received at a later date from other organisations such as Kidney Research UK. Trustees may make use of consultants to moderate areas requiring research, but fees will not be paid for this advice.
## **Activities undertaken to achieve objectives**
The Charity makes use of the considerable knowledge and contacts available through its Trustees and the members of its committees to ensure that it is aware of all relevant projects and posts. As the demand for funding exceeds the supply of funds available to it, the Charity is able to choose those projects and posts that most closely match its objectives.
## **Achievements and performance**
## **Review of activities**
The Charity has made or committed grants during the year of £155,280 analysed in note 9 to the financial statements (2024: £96,688)
The surplus for the year amounted to £149,290 (2024: £119,223). The surplus after net investment losses of £14,208 (2024 gains: £26,546) amounted to £135,082 (2024: surplus £145,769). Legacies receivable in the year amounted to £247,726 (2024: £184,444).
## **Investment performance**
Investments held by the Charity at 5 April 2025 have been made in accordance with the powers and policy noted below. Trustees are satisfied with the performance of investments, which have overall yielded average income of 3.1% excluding interest from cash deposits.
Page 2
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2025**
## **Financial review**
## **Going concern**
After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
## **Reserves policy**
It is considered prudent to maintain cash reserves at approximately thirty months' expected future expenditure (that being the average length of time to complete a research project) and to ensure that existing free reserves cover future commitments. At the year end, free reserves (cash and investments) amounted to £887,226 (2024: £752,144), well in excess of the reserve policy, which will allow the Charity to continue to fund research projects beyond existing commitments.
## **Investments policy**
The Trustees are authorised under the trust deed to invest or apply the Charity's monies without restriction as they see fit.
Whilst the Trust Deed allows Trustees to liquidate investments and apply the proceeds towards the objects of the Charity, the Trustees' current policy is to use the income generated by investments towards research but to maintain the capital. A cautious risk policy is applied.
The day-to-day management of investments has been delegated to Barclays Wealth. The Trustees review the investment holdings at each meeting for performance and compliance with policies.
## **Principal funding**
The Charity's main source of funding is donations and legacies from members of the public. It does not rely on investment income alone.
## **Structure, governance and management**
## **Constitution**
Northern Counties Kidney Research Fund is a registered charity, number 700037.
The principal object of the Charity is to finance research projects relating to kidney disorder in the North of England. The Charity was established by a trust deed dated 18 March 1988.
There have been no changes in the objectives since the last annual report.
## **Methods of appointment or election of Trustees**
Trustees are appointed in accordance with the memorandum of appointment under the Charities Act 2011. New Trustees can be nominated by existing Trustees.
Page 3
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
**TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2025**
## **Structure, governance and management (continued)**
## **Organisational structure and decision-making policies**
Trustees have delegated the decision making process to a committee of unpaid individuals with relevant experience in the fields of medicine, finance and the law. This committee deals with fundraising, marketing and investment decisions. It receives funding recommendations from a scientific sub-committee onto which scientists are co-opted as necessary. Committee meetings are held on a quarterly basis.
Trustees meet at least three times a year to receive and approve all recommendations from the committee and other applications for funds.
## **Policies adopted for the induction and training of Trustees**
There are no formal procedures for the induction and training of Trustees. Senior Trustees ensure, on an informal basis, that new Trustees are given adequate information to ensure that they have knowledge of the Charity and their role within it.
## **Related party relationships**
The majority of the Trustees and committee members are employed by organisations to which the Charity makes grants, primarily Newcastle University, the Freeman Hospital and the Royal Victoria Infirmary in Newcastle-upon-Tyne. Neither Trustees nor committee members take part in any decisions of the Charity where they, or a project with which they have an interest, might benefit.
## **Financial risk management**
The ability of the Charity to provide research funding is dependent upon legacy income and fundraising. The Trustees continue to encourage the provision of legacy income through constant publicity wherever possible, and to promote fundraising activities throughout each year. Monitoring of legacies is managed by an independent consultant on behalf of the Trustees.
The Charity's investment portfolio is subject to market fluctuations. To mitigate this risk the investments are managed by Barclays Wealth within their discretionary Charity Fund portfolio.
There is a risk that resources are paid out to research projects that are not soundly based. All funding requests are scrutinised by the scientific sub-committee who assess the efficacy of the requests made prior to recommendation to the main committee for approval.
## **Plans for future periods**
In the coming year, the Charity will continue to provide charitable support in accordance with its objectives. In particular, the Charity will consider applications for ongoing scientific research and support of research orientated PhD projects associated with kidney disease.
Page 4
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 5 APRIL 2025**
## **Statement of Trustees' responsibilities**
The Trustees are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England & Wales requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles of the Charities SORP (FRS 102);
- make judgments and accounting estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust deed. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees on 21 October 2025 and signed on their behalf by:
## **JA Kirby**
Page 5
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 5 APRIL 2025**
## **Independent examiner's report to the Trustees of Northern Counties Kidney Research Fund ('the Charity')**
I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 5 April 2025.
## **Responsibilities and basis of report**
As the Trustees of the Charity you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the 2011 Act').
I report in respect of my examination of the Charity's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
## **Independent examiner's statement**
Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.
Your attention is drawn to the fact that the Charity has prepared the accounts in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has been withdrawn.
I understand that this has been done in order for the accounts to provide a true and fair view in accordance with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the Charity as required by section 130 of the 2011 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent examiner's report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.
Signed:
Dated: 22 October 2025
Deborah Graham FCA
Ryecroft Glenton 32 Portland Terrace Newcastle upon Tyne NE2 1QP
Page 6
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 5 APRIL 2025**
|**Note**
**Income from:**
Donations and legacies
3
Other activities
4
Investments
5
Other income
6
**Total income**
**Expenditure on:**
Raising funds
7,8
Charitable activities
**Total expenditure**
**Net income before net (losses)/gains on**
**investments**
Net (losses)/gains on investments
**Net movement in funds**
**Reconciliation of funds:**
Total funds brought forward
Net movement in funds
**Total funds carried forward**|**Unrestricted**
**funds**
**2025**
**£**
**299,529**
**7,406**
**18,018**
**270**
**325,223**
**11,757**
**164,176**
**175,933**
**149,290**
**(14,208)**
**135,082**
**752,144**
**135,082**
**887,226**|**Total**
**funds**
**2025**
**£**
**299,529**
**7,406**
**18,018**
**270**
**325,223**
**11,757**
**164,176**
**175,933**
**149,290**
**(14,208)**
**135,082**
**752,144**
**135,082**
**887,226**|_Total_
_funds_
_2024_
_£_
_210,556_
_-_
_16,263_
_-_|
|---|---|---|---|
||||_226,819_|
||||_6,081_
_101,515_|
||||_107,596_|
||||_119,223_
_26,546_|
||||_145,769_|
||||_606,375_
_145,769_|
||||_752,144_|
The Statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 9 to 19 form part of these financial statements.
Page 7
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **BALANCE SHEET AS AT 5 APRIL 2025**
||||**2025**|**2025**||_2024_|
|---|---|---|---|---|---|---|
||**Note**||**£**|||_£_|
|**Fixed assets**|||||||
|Investments|13||**384,121**|||_399,517_|
||||**384,121**|||_399,517_|
|**Current assets**|||||||
|Debtors|14|**43,692**|||_40,337_||
|Cash at bank and in hand||**634,628**|||_466,146_||
|||**678,320**|||_506,483_||
|**Current liabilities**|||||||
|Creditors: amounts falling due within one|||||||
|year|15|**(175,215)**|||_(153,856)_||
|**Net current assets**|||**503,105**|||_352,627_|
|**Total assets less current liabilities**|||**887,226**|||_752,144_|
|**Total net assets**|||**887,226**|||_752,144_|
|**Charity funds**|||||||
|Unrestricted funds|16||**887,226**|||_752,144_|
|**Total funds**|||**887,226**|||_752,144_|
The financial statements were approved and authorised for issue by the Trustees on 21 October 2025 and signed on their behalf by:
**JA Kirby** (Chair of Trustees)
The notes on pages 9 to 19 form part of these financial statements.
Page 8
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **1. General information**
Northern Counties Kidney Research Fund is a grant making charitable trust registered in England, charity registration number 700037. The principal office is Level 4 Podium Block, Freeman Hospital, Newcastle upon Tyne, NE7 7DN.
## **2. Accounting policies**
## **2.1 Basis of preparation of financial statements**
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Charities Act 2011.
The presentational currency is GBP.
The financial statements have been prepared to give a 'true and fair' view and have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true and fair' view. This departure has involved following the Charities SORP (FRS 102) published in October 2019 rather than the Accounting and Reporting by Charities: Statement of Recommended Practice effective from 1 April 2005 which has since been withdrawn.
Northern Counties Kidney Research Fund meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
## **2.2 Income**
All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Charity has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Charity, can be reliably measured.
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
## **2.3 Expenditure**
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
Expenditure on raising funds includes all expenditure incurred by the Charity to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.
Page 9
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **2. Accounting policies (continued)**
## **2.3 Expenditure (continued)**
Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.
Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.
All expenditure is inclusive of irrecoverable VAT.
## **2.4 Interest receivable**
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
## **2.5 Investments**
Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of financial activities.
## **2.6 Financial instruments**
The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
## **2.7 Fund accounting**
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.
Investment income, gains and losses are allocated to the appropriate fund.
Page 10
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **3. Income from donations and legacies**
|**Unrestricted**
**funds**
**2025**
**£**
Donations
51,803
Legacies
247,726
**Total 2025**
299,529
_Unrestricted_
_funds_
_2024_
_£_
Donations
_26,112_
Legacies
_184,444_
_Total 2024_
_210,556_|**Total**
**funds**
**2025**
**£**
**51,803**
**247,726**|
|---|---|
||**299,529**|
||_Total_
_funds_
_2024_
_£_
_26,112_
_184,444_|
||_210,556_|
## **4. Income from other activities**
## **Income from fundraising events**
||**Unrestricted**|**Total**|_Total_|
|---|---|---|---|
||**funds**|**funds**|_funds_|
||**2025**|**2025**|_2024_|
||**£**|**£**|_£_|
|Burns night dinner|7,406|**7,406**|_-_|
Page 11
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **5. Investment income**
|**Unrestricted**
**funds**
**2025**
**£**
Investment income
12,232
Interest receivable
5,786
**Total 2025**
18,018
_Unrestricted_
_funds_
_2024_
_£_
Investment income
_11,683_
Interest receivable
_4,580_
_Total 2024_
_16,263_|**Total**
**funds**
**2025**
**£**
**12,232**
**5,786**|
|---|---|
||**18,018**|
||_Total_
_funds_
_2024_
_£_
_11,683_
_4,580_|
||_16,263_|
## **6. Other incoming resources**
||**Unrestricted**|**Total**|_Total_|
|---|---|---|---|
||**funds**|**funds**|_funds_|
||**2025**|**2025**|_2024_|
||**£**|**£**|_£_|
|Returned grants|270|**270**|_-_|
Page 12
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **7. Expenditure on raising funds**
## **Costs of raising voluntary income**
|**Unrestricted**
**funds**
**2025**
**£**
Just Giving fees
216
Great North Run fees
4,067
Burns night costs
6,066
**Total 2025**
10,349
_Unrestricted_
_funds_
_2024_
_£_
Just Giving fees
_215_
Great North Run fees
_5,192_
_Total 2024_
_5,407_|**Total**
**funds**
**2025**
**£**
**216**
**4,067**
**6,066**|
|---|---|
||**10,349**|
||_Total_
_funds_
_2024_
_£_
_215_
_5,192_|
||_5,407_|
## **8. Investment management costs**
||**Unrestricted**|**Total**|
|---|---|---|
||**funds**|**funds**|
||**2025**|**2025**|
||**£**|**£**|
|Investment management fees|1,408|**1,408**|
Page 13
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **8. Investment management costs (continued)**
||_Unrestricted_|_Total_|
|---|---|---|
||_funds_|_funds_|
||_2024_|_2024_|
||_£_|_£_|
|Investment management fees|_674_|_674_|
## **9. Analysis of grants**
|Grants paid to institutions
Grants paid to institutions|**Grants to**
**Institutions**
**2025**
**£**
155,280
_Grants to_
_Institutions_
_2024_
_£_
_96,688_|**Total**
**funds**
**2025**
**£**
**155,280**|
|---|---|---|
|||_Total_
_funds_
_2024_
_£_
_96,688_|
The Charity has made the following material grants to institutions during the year:
|**Name of institution**
University of Newcastle-upon-Tyne
Kidney Research UK|**2025**
**£**
**115,280**
**40,000**
**155,280**
**155,280**|_2024_
_£_
_96,688_
_-_|
|---|---|---|
|||_96,688_|
||||
|||_96,688_|
Page 14
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **10. Analysis of expenditure by activities**
|Direct costs - grant making and support
Direct costs - grant making and support|**Grant**
**funding of**
**activities**
**2025**
**£**
155,280
_Grant_
_funding of_
_activities_
_2024_
_£_
_96,688_|**Support**
**costs**
**2025**
**£**
8,896
_Support_
_costs_
_2024_
_£_
_4,827_|**Total**
**funds**
**2025**
**£**
**164,176**|
|---|---|---|---|
||||_Total_
_funds_
_2024_
_£_
_101,515_|
## **Analysis of support costs**
|Books and publications
Insurance
Miscellaneous expenses
Consultancy fees
Governance costs|**Activities**
**2025**
**£**
628
575
473
2,078
5,142
8,896|**Total**
**funds**
**2025**
**£**
**628**
**575**
**473**
**2,078**
**5,142**|
|---|---|---|
|||**8,896**|
Page 15
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **10. Analysis of expenditure by activities (continued)**
## **Analysis of support costs (continued)**
|Books and publications
Insurance
Governance costs
_Total 2024_
**11.**
**Independent examiner's remuneration**
Fees payable to the Charity's independent examiner|_Activities_
_2024_
_£_
_1,293_
_558_
_2,976_
_4,827_
**2025**
**£**
**3,465**|_Total_
_funds_
_2024_
_£_
_1,293_
_558_
_2,976_|
|---|---|---|
|||_4,827_|
|||_2024_
_£_
_3,300_|
## **12. Trustees' remuneration and expenses**
During the year, no Trustees received any remuneration or other benefits _(2024 - £NIL)_ .
During the year, no Trustees' expenses have been incurred _(2024 - £NIL)_ .
Page 16
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
|**13.**
**Fixed asset investments**
**Cost or valuation**
At 6 April 2024
Disposals
Revaluations
At 5 April 2025
**Net book value**
At 5 April 2025
_At 5 April 2024_
**14.**
**Debtors**
**Due within one year**
Prepayments and accrued income
**15.**
**Creditors: Amounts falling due within one year**
Grants authorised, not yet paid
Accruals|**2025**
**£**
**43,692**
**43,692**
**2025**
**£**
**171,057**
**4,158**
**175,215**|**Listed**
**investments**
**£**
**399,517**
**(1,188)**
**(14,208)**
**384,121**
**384,121**
_399,517_
_2024_
_£_
_40,337_
_40,337_
_2024_
_£_
_150,880_
_2,976_
_153,856_|
|---|---|---|
Page 17
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **16. Statement of funds**
## **Statement of funds - current year**
||**Balance at 6**|||**Gains/**|**Balance at 5**|
|---|---|---|---|---|---|
||**April 2024**|**Income**|**Expenditure**|**(Losses)**|**April 2025**|
||**£**|**£**|**£**|**£**|**£**|
|**Unrestricted funds**||||||
|General Funds|**752,144**|**325,223**|**(175,933)**|**(14,208)**|**887,226**|
|**Statement of funds - prior year**||||||
||_Balance at_|||_Gains/_|_Balance at_|
||_1 April 2023_|_Income_|_Expenditure_|_(Losses)_|_5 April 2024_|
||_£_|_£_|_£_|_£_|_£_|
|**Unrestricted funds**||||||
|General Funds|_606,375_|_226,819_|_(107,596)_|_26,546_|_752,144_|
## **17. Analysis of net assets between funds Analysis of net assets between funds - current year**
|**Unrestricted**
**funds**
**2025**
**£**
Fixed asset investments
384,121
Current assets
678,320
Creditors due within one year
(175,215)
**Total**
887,226|**Total**
**funds**
**2025**
**£**
**384,121**
**678,320**
**(175,215**|
|---|---|
||**887,226**|
Page 18
Docusign Envelope ID: 6C1A5F3D-0931-4CCE-AC5A-317F80557793
## **NORTHERN COUNTIES KIDNEY RESEARCH FUND**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 5 APRIL 2025**
## **17. Analysis of net assets between funds (continued)**
## **Analysis of net assets between funds - prior year**
|Fixed asset investments
Current assets
Creditors due within one year
**Total**|_Unrestricted_
_funds_
_2024_
_£_
_399,517_
_506,483_
_(153,856)_
_752,144_|_Total_
_funds_
_2024_
_£_
_399,517_
_506,483_
_(153,856)_
_752,144_|
|---|---|---|
## **18. Related party transactions**
In view of the relationship of certain Trustees with the University of Newcastle-upon-Tyne, who receives grant funding from the Charity, any potential conflict is managed between the Trustees and the University such that members of the scientific sub-committee cannot vote on any recommendations from it to the main committee. All grants to the University of Newcastle-upon-Tyne are fully disclosed in these financial statements.
Page 19